Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

about

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q35959738

description

1976 nî lūn-bûn

@nan

1976年の論文

@ja

1976年論文

@yue

1976年論文

@zh-hant

1976年論文

@zh-hk

1976年論文

@zh-mo

1976年論文

@zh-tw

1976年论文

@wuu

1976年论文

@zh

1976年论文

@zh-cn

name

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@ast

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@en

type

Item

label

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@ast

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@en

prefLabel

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@ast

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@en

P1476

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

@en

P2093

Barbeau A

http://www.w3.org/2001/XMLSchema#string

Roy M

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone

Treatment of parkinsonism with levodopa.

Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.

Isolation and structure of hypothalamic MSH release-inhibition hormone.

Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

Dopamine synthesis: stimulation by a hypothalamic factor.

DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.

Melanocyte-stimulating hormone and the hypothalamic hormone which inhibits its release.

P304

120-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Abba J. Kastin

P577

1976-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3279

http://www.w3.org/2001/XMLSchema#string

P932

1956816

http://www.w3.org/2001/XMLSchema#string